Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Vervliet

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Immunology|September 1, 1985
In vitro correction of the interleukin-2 and interferon-gamma defect in multiple sclerosisG Vervliet, L Schandené
Immunology Today|October 8, 2014
The murine IL-2-dependent cytotoxic T-cell line CTLL can be preserved by freezingG Vervliet, G Volckaert
Immunology Today|October 8, 2014
Sponsoring science - successfully?A Billiau, G Vervliet
Clinical and Experimental Immunology|February 1, 1985
Interferon-gamma production by peripheral blood leucocytes from patients with multiple sclerosis and other neurological diseasesG Vervliet, H Carton, A Billiau
Clinical and Experimental Immunology|October 1, 1984
Interferon production by cultured peripheral leucocytes of MS patientsG Vervliet, H Carton, E Meulepas, et al.
Journal of Clinical Immunology|March 1, 1985
Influence of prostaglandin E2 and indomethacin on interferon-gamma production by cultured peripheral blood leukocytes of multiple sclerosis patients and healthy donorsG Vervliet, H Deckmyn, H Carton, et al.
The Journal of General Virology|January 1, 1975
Characterization of different plaque-forming and defective temperate phages in AgrobacteriumG Vervliet, M Holsters, H Teuchy, et al.
Journal of the Neurological Sciences|July 1, 1983
Interferon production and natural killer (NK) activity in leukocyte cultures from multiple sclerosis patientsG Vervliet, H Claeys, H Van Haver, et al.
Neurology|October 1, 1986
Transfer factor therapy in multiple sclerosis: a three-year prospective double-blind clinical trialH Van Haver, F Lissoir, C Droissart, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Immunology|September 1, 1985
In vitro correction of the interleukin-2 and interferon-gamma defect in multiple sclerosisG Vervliet, L Schandené
Immunology Today|October 8, 2014
The murine IL-2-dependent cytotoxic T-cell line CTLL can be preserved by freezingG Vervliet, G Volckaert
Immunology Today|October 8, 2014
Sponsoring science - successfully?A Billiau, G Vervliet
Clinical and Experimental Immunology|February 1, 1985
Interferon-gamma production by peripheral blood leucocytes from patients with multiple sclerosis and other neurological diseasesG Vervliet, H Carton, A Billiau
Clinical and Experimental Immunology|October 1, 1984
Interferon production by cultured peripheral leucocytes of MS patientsG Vervliet, H Carton, E Meulepas, et al.
Journal of Clinical Immunology|March 1, 1985
Influence of prostaglandin E2 and indomethacin on interferon-gamma production by cultured peripheral blood leukocytes of multiple sclerosis patients and healthy donorsG Vervliet, H Deckmyn, H Carton, et al.
The Journal of General Virology|January 1, 1975
Characterization of different plaque-forming and defective temperate phages in AgrobacteriumG Vervliet, M Holsters, H Teuchy, et al.
Journal of the Neurological Sciences|July 1, 1983
Interferon production and natural killer (NK) activity in leukocyte cultures from multiple sclerosis patientsG Vervliet, H Claeys, H Van Haver, et al.
Neurology|October 1, 1986
Transfer factor therapy in multiple sclerosis: a three-year prospective double-blind clinical trialH Van Haver, F Lissoir, C Droissart, et al.
Pageof 1